China NMPA Inspection - Chengdu Hengbo Medical Devices Co., Ltd. - November 23, 2016

An unannounced inspection of Chengdu Hengbo Medical Device Co., Ltd. culminated in a report published on November 23, 2016, by the Sichuan Provincial Food and Drug Administration. This regulatory oversight revealed critical shortcomings in the company's operations. Specifically, the inspection determined that Chengdu Hengbo Medical Device Co., Ltd. was not in compliance with the relevant requirements of the Good Manufacturing Practice (GMP) for Medical Devices. These findings pointed to significant deficiencies within the company's overall quality management system, which is essential for ensuring the safety, efficacy, and quality of medical products. Operating under the broader regulatory framework overseen by the National Medical Products Administration (NMPA), the Sichuan Provincial Food and Drug Administration deemed these violations serious enough to warrant immediate and stringent action. Consequently, Chengdu Hengbo Medical Device Co., Ltd. was issued an order to forthwith cease all production activities. Furthermore, the company was mandated to implement comprehensive rectification measures to address and correct the identified non-compliances and deficiencies. This regulatory intervention highlights the authorities' commitment to upholding rigorous manufacturing standards and protecting public health through strict enforcement of medical device regulations.